Taking Stock of the Latest Research in Parkinson’s Disease Management: A Clinical Update From Washington, DC

Creating A CME for stroke is the absolute minimum that the ASA, NSA and WSO should be doing.  But that won't occur under the current leadership.
http://peerviewpress.com/taking-stock-latest-research-parkinson%E2%80%99s-disease-management-clinical-update-washington-dc?

Activity Description & Educational Objectives

In this video-based activity, an expert in Parkinson’s disease (PD) discusses recently presented data on new and established treatment approaches for the management of motor symptoms and motor complications, as well as non–motor symptoms, in individuals with advanced PD.
Upon completion of this activity, participants should be better able to:

• Apply new efficacy, safety, and tolerability data on approved therapies for the management of motor symptoms in patients with early Parkinson’s disease (PD)
• Employ late-breaking efficacy, safety, and tolerability data on therapeutic strategies for the management of motor complications in patients with advanced PD
• Assess recently presented data on the management of non–motor symptoms in patients with PD

Target Audience

This activity has been designed to meet the educational needs of neurologists and other clinicians involved in the management of PD.

Requirements for Successful Completion

In order to receive credit, participants must view the activity and complete the post-test and evaluation form. There are no pre-requisites and there is no fee to participate in this activity or to receive CME credit. Statements of Credit are awarded upon successful completion of the post-test and evaluation form.